N/A
N=196
Trial on the Effectiveness of Mindfulness Training for Smokers
Nicotine Dependence
Bottom Line
View on ClinicalTrials.gov: NCT01093599 ↗Enrolled (actual)
196
Serious AEs
0.0%
Results posted
Feb 2015
Primary outcome: Primary: Smoking Abstinence — 13; 24 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Quit Line plus MTS (Behavioral); Quit Line Only (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Wisconsin, Madison
- Primary completion
- Dec 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Smoking Abstinence |
13; 24 | — |
| SECONDARY Changes in Self Reported Measures of Depression, Anxiety and Stress in Study Subjects vs Controls |
— | — |
Summary
The Mindfulness Training for Smokers study follows a randomized controlled design with 240 total participants. Both the study group and the control group will be enrolled in the Wisconsin Tobacco Quit Line and will receive four weeks of nicotine patches. The control group will receive the Quit Line intervention alone where as the study group will receive the Quit Line intervention plus the Mindfulness for Smokers Intervention. The Mindfulness for Smokers Intervention provides four weeks of instruction in mindfulness meditation followed by four weeks of participation in a weekly meditation group. The principal hypothesis for the study is that Mindfulness for Smokers plus the Quit Line will lead to significantly higher rates of smoking cessation at 6 months than the Quit Line alone.
Eligibility Criteria
Inclusion Criteria
- Age: 18 years or over;
- Participants must express "high" motivation to quit smoking
- Participants must express willingness to attend "all" meetings for 2 months.
- Smoke 5 or more cigarettes per day
Exclusion Criteria
- Self report of alcohol use of 4 drinks or more a night on 4 or more nights per week.
- Self report of using chewing tobacco, snuff or cigars in the last week.
Data sourced from ClinicalTrials.gov (NCT01093599). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.